China National Accord Medi (000028.SZ) traded flat 0 % during a 24 hours period ending at 07:15 PM Central Europe on Monday 26th. One China National Accord Medi stock can currently be bought for about CNY 21.06 on popular exchanges. Current supply of China National Accord Medi stocks is 573.6 mn. China National Accord Medi has a current market capitalization of CNY 11.8 bn and approximately CNY 101.4 mn worth of China National Accord Medi was traded on exchanges in the last 24 hours. Since last month end, China National Accord Medi has traded 5.85 % up. Simple moving average of last 200 days is at CNY 20.28. The highest price of past 52 weeks was recorded at CNY 24.94 on 01/27/2026. 52 weeks low was at CNY 18.7 on 06/29/2026.

Here is how related stocks have performed in the past 24 hours:

  • Sino-platinum Metals (600459.SS) traded flat 0 % and now trades at CNY 16.89. Current market capitalisation for Sino-platinum Metals is CNY 14.2 bn. Current price/earnings ratio for Sino-platinum Metals is 19.71.

  • Dongfang Electronics Lt (000682.SZ) traded flat 0 % and now trades at CNY 9.84. Dongfang Electronics Lt has a market capitalisation of CNY 14.2 bn. Dongfang Electronics Lt has a current price to earnings ratio of 14.02.

  • Kaishan (300257.SZ) traded flat 0 % and now trades at CNY 13.88. Current market capitalisation for Kaishan is CNY 14.1 bn. Kaishan has a current price to earnings ratio of 38.24.

  • Jinyu Bio- Lt (600201.SS) traded flat 0 % and now trades at CNY 13.02. Jinyu Bio- Lt has a market capitalisation of CNY 14.1 bn. Jinyu Bio- Lt has a current price to earnings ratio of 102.36. JINYU BIO‑TECHNOLOGY CO LT’s activities were highlighted at the 2026 European Society for Medical Oncology conference, where a substantial proportion of breakthrough abstracts involved Chinese innovation. The company’s work on antibody‑drug conjugates and other engineered therapeutics was among the presentations that attracted attention for its potential clinical impact. Analysts noted that the inclusion of these studies in the highest‑tier forum signals a growing confidence in the global competitiveness of Chinese‑origin drugs. Discussions also touched on the strategic shift toward clinical validation and international registration, suggesting that JINYU BIO‑TECHNOLOGY CO LT may pursue further collaborations to enhance its market reach.

  • Xinyi Solar (0968.HK) traded down -0.27 % and now trades at HKD 1.84. Xinyi Solar has a market capitalisation of HKD 16.6 bn. Xinyi Solar has a current price to earnings ratio of 102.56.

About China National Accord Medi

China National Accord Medicines Corp. Ltd. is a health care provider and service company operating in the Shenzhen sector with its main base located in China. The company specializes in developing and manufacturing pharmaceuticals, as well as wholesaling and retailing patent medicines, Chinese traditional medicines, biological products, healthcare products, and medical instruments. You can find more information about their offerings on their website at www.szaccord.com.cn , and they are listed on the Shenzhen Stock Exchange. Their Initial Public Offering (IPO) date was May 5, 1993.